Closed · RFA-FD-14-003 · CFDA 93.103 · Discretionary

Convener of Discussions on Medical Policy Issues Impacting Drug Development

Federal grant opportunity posted by Food and Drug Administration, cataloged on Grants.gov.

$550K-$600K
Award range
Closed
Status
June 2, 2014
Close date
5
Expected awards

The verdict

Convener of Discussions on Medical Policy Issues Impacting Drug Development is a closed discretionary listing from Food and Drug Administration that offered $550,000 -- $600,000 across 5 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 481 other opportunities from Food and Drug Administration.

$550K-$600K
award range
Closed
application status
5
expected awards
93.103
CFDA program

Archived opportunity record

Convener of Discussions on Medical Policy Iss… is closed (last close June 2, 2014). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 2, 2014

Posted Mar 31 Closes Jun 2

Est. Total Funding

$600,000

Expected Awards

5

Instrument

Cooperative Agreement

Description

The Office of Medical Policy (OMP) provides CDER oversight and leadership in the development of medical policy, procedures, and policy initiatives pertaining to drug development, drug approval, bioresearch monitoring, human subject protection and post market surveillance processes. When developing and implementing policy, a key step is often to create a broad public forum with a variety of stakeholders to identify key issues that will need to be addressed before, during, and after implementation of any initiative. These discussions can help focus many of the policy and procedural needs of an evolving initiative. The goal of such meetings is not to obtain advice relating to regulatory actions or to make decisions. Nor is the goal to reach a consensus among the participants on any of the issues discussed. Rather, it is to hear the opinions of experts in the field and other individual stakeholders. In addition, it is important to maintain transparency. The goal of these meetings is to be as inclusive as possible, while still limiting participation to a number that supports the meetings goals and objectives. However, it is important to ensure that information from these meetings and working groups must be described, managed, and made available to the public using a transparent and open approach.

Multi-door applicant board · 2 Grants.gov types

Grants.gov prints 2 distinct applicant types for Convener of Discussions on Medical Policy Iss… (Nonprofits with 501(c)(3) status (other than IHEs); Nonprofits without 501(c)(3) status (other than IHEs)). Filter fit against the official announcement before drafting. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Education · Health · Science and Technology / R&D (ED;HL;ST). Only 12 other Food and Drug Administration listings share this exact eligibility-code string (2% of 482).

Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Gladys Melendez-Bohler Grants Management Specialist Phone 301-827-7175

What to do next

Convener of Discussions on Medical Policy Iss… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.103 may publish future NOFOs under the same assistance listing. Open program
  • Food and Drug Administration Research indexes 42 Grants.gov listings in this extract. Program profile
  • Food and Drug Administration lists 481 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants